PMID- 33718501
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220421
IS  - 2325-9671 (Print)
IS  - 2325-9671 (Electronic)
IS  - 2325-9671 (Linking)
VI  - 9
IP  - 2
DP  - 2021 Feb
TI  - Defining the Clinically Meaningful Outcomes for Arthroscopic Treatment of 
      Femoroacetabular Impingement Syndrome at Minimum 10-Year Follow-up: The Timing of 
      Surgery Is Crucial.
PG  - 2325967120985140
LID - 10.1177/2325967120985140 [doi]
LID - 2325967120985140
AB  - BACKGROUND: Arthroscopic treatment of femoroacetabular impingement syndrome 
      (FAIS) has become a common procedure. However, meaningful long-term clinical 
      outcomes have not been defined. PURPOSE: To define the minimal clinically 
      important difference (MCID), substantial clinical benefit (SCB), and patient 
      acceptable symptomatic state (PASS) for the modified Harris Hip Score (mHHS) at a 
      minimum 10-year follow-up in patients undergoing arthroscopic treatment for FAIS 
      and identify preoperative predictors for achievement of the MCID, SCB, and PASS. 
      STUDY DESIGN: Case-control study; Level of evidence, 3. METHODS: A consecutive 
      series of patients undergoing arthroscopic treatment for FAIS between 2007 and 
      2009 with a minimum 10-year follow-up was analyzed. Patient data included patient 
      characteristics, radiographic parameters, and the pre- and postoperative mHHS and 
      visual analog scale (VAS) for pain score. Paired t tests were used to compare the 
      patient-reported outcome measures (PROMs). The MCID was determined by calculating 
      half of the standard deviation, and SCB and PASS were calculated by the anchor 
      method. Correlation and logistic regression analyses were conducted to identify 
      predictors for the achievement of the MCID, SCB, and PASS. RESULTS: A total of 44 
      patients (27 men, 17 women) were included. The mean age and body mass index were 
      42.2 years (range, 16-67 years) and 22.3 kg/m(2) (range, 16.76-29.78 kg/m(2)), 
      respectively. The MCID, absolute SCB, net change SCB, and PASS of the mHHS were 
      calculated to be 19.6, 90.1, 31.5, and 84.4 points, respectively. Preoperative 
      symptom duration was identified as an independent predictor for the achievement 
      of meaningful clinical outcomes. The median symptom durations for patients who 
      achieved the MCID, absolute SCB, net change SCB, and PASS were 11.7, 9.1, 9.0, 
      and 10.8 months, respectively. The median symptom duration for patients who did 
      not achieve the MCID, absolute SCB, net change SCB, and PASS were 15.8, 17.4, 
      17.3, and 18.4 months, respectively. No other statistically significant 
      correlations were found. CONCLUSION: The preoperative duration of symptoms was 
      identified as an independent predictor for achievement of the MCID, SCB, and 
      PASS. These findings can be helpful in accelerating the transition to surgical 
      treatment of FAIS.
CI  - (c) The Author(s) 2021.
FAU - Zimmerer, Alexander
AU  - Zimmerer A
AD  - ARCUS Sportklinik Pforzheim, Germany.
AD  - Department of Orthopaedics, University Medicine Greifswald, Greifswald, Germany.
FAU - Janz, Viktor
AU  - Janz V
AD  - Department of Orthopaedics, University Medicine Greifswald, Greifswald, Germany.
FAU - Sobau, Christian
AU  - Sobau C
AD  - ARCUS Sportklinik Pforzheim, Germany.
FAU - Wassilew, Georgi I
AU  - Wassilew GI
AD  - Department of Orthopaedics, University Medicine Greifswald, Greifswald, Germany.
FAU - Miehlke, Wolfgang
AU  - Miehlke W
AD  - ARCUS Sportklinik Pforzheim, Germany.
LA  - eng
PT  - Journal Article
DEP - 20210225
PL  - United States
TA  - Orthop J Sports Med
JT  - Orthopaedic journal of sports medicine
JID - 101620522
PMC - PMC7922622
OTO - NOTNLM
OT  - 10-year follow-up
OT  - MCID
OT  - PASS
OT  - SCB
OT  - femoroacetabular impingement syndrome
COIS- One or more of the authors has declared the following potential conflict of 
      interest or source of funding: W.M. has received personal fees from Arthrex and 
      Richard Wolf. AOSSM checks author disclosures against the Open Payments Database 
      (OPD). AOSSM has not conducted an independent investigation on the OPD and 
      disclaims any liability or responsibility relating thereto.
EDAT- 2021/03/16 06:00
MHDA- 2021/03/16 06:01
PMCR- 2021/02/25
CRDT- 2021/03/15 07:09
PHST- 2020/08/27 00:00 [received]
PHST- 2020/09/21 00:00 [accepted]
PHST- 2021/03/15 07:09 [entrez]
PHST- 2021/03/16 06:00 [pubmed]
PHST- 2021/03/16 06:01 [medline]
PHST- 2021/02/25 00:00 [pmc-release]
AID - 10.1177_2325967120985140 [pii]
AID - 10.1177/2325967120985140 [doi]
PST - epublish
SO  - Orthop J Sports Med. 2021 Feb 25;9(2):2325967120985140. doi: 
      10.1177/2325967120985140. eCollection 2021 Feb.